Radicut® 30 mg Injection (Edaravone) is an original Japanese pharmaceutical product containing 30 mg of edaravone in a 20 mL infusion solution. The medication is widely recognized for its antioxidant and neuroprotective properties and is used in neurological practice to reduce oxidative damage to nerve cells.
Edaravone has been approved in several countries for the treatment of Amyotrophic Lateral Sclerosis (ALS) and has also been used in acute ischemic stroke management in certain healthcare systems.
By scavenging free radicals, Radicut helps protect neurons and may support the preservation of neurological function.
Active ingredient:
Dosage form:
Package contents:
Edaravone is a potent free radical scavenger that:
Its neuroprotective activity has made it an important treatment option in modern neurology.
Radicut is used to help slow functional decline in patients with ALS.
In some countries, edaravone is used as part of comprehensive stroke management protocols.
The drug may be prescribed under specialist supervision in conditions associated with increased oxidative stress.
Radicut is administered by healthcare professionals only.
The medication is typically given:
Treatment duration and dosing depend on the patient's condition and medical assessment.
Do not use in cases of:
Medical supervision is required.
Potential adverse reactions may include:
Consult a healthcare provider if side effects occur.
Radicut is an injectable edaravone medication used for neuroprotective antioxidant therapy.
Edaravone is used to reduce oxidative damage and support nerve cell protection, particularly in ALS treatment.
No. Radicut is not a cure but may help slow functional decline in certain patients.
The medication is administered intravenously by qualified healthcare professionals.
One package contains 10 ampoules of 20 mL each.
Yes. In most countries Radicut is available by prescription only.
Ask a question or inquire about delivery to your country


